| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $60.0M | +125.7% |
| R&D Expense | $120.2M | -4.8% |
| SG&A Expense | $33.5M | +5.5% |
| Operating Income | -$93.7M | +28.7% |
| Pre-tax Income | -$79.0M | +38.0% |
| Income Tax | $0 | — |
| Net Income | -$79.0M | +38.0% |
| EPS (Basic) | -$1.39 | +46.5% |
| EPS (Diluted) | -$1.39 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.7M | +48.5% |
| Short-term Investments | $154.9M | +38.8% |
| Current Assets | $355.6M | +46.3% |
| Total Assets | $358.0M | +44.4% |
| Current Liabilities | $21.3M | -31.8% |
| Total Liabilities | $21.3M | -34.2% |
| Stockholders' Equity | $336.7M | +56.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.2M | +35.0% |
| Capital Expenditures | $609K | -23.4% |
| Investing Cash Flow | -$39.3M | -142.9% |
| Financing Cash Flow | $170.5M | +805.0% |
| Free Cash Flow | -$70.8M | +35.0% |
| +46.5% |